Source: Getty Images

Liquid Biopsy to Detect PD-L1 Bolsters Case for PD-1 inhibitors

Research marks the first time liquid biopsy has been used in lung cancer patients to determine patients likely to respond to PD-1 inhibitors
Qiagen plans to acquire diagnostics developer STAT-Dx for up to $191 million

Qiagen to Acquire Diagnostics Developer STAT-Dx for $147M, Plus Milestones

Later this year, combined company plans to launch QIAstat-Dx, designed for use in oncology and respiratory or gastrointestinal infections

Irish CRO ICON Acquires MolecularMD

The buyout enhances ICON's molecular diagnostic testing while expanding its testing platforms to include next-generation sequencing and IHC
Source: © Robert Mizerek/

Roche Acquires Signature Diagnostics

Roche has acquired Signature Diagnostics for an undisclosed price. The deal is designed to strengthen Roche’s cancer diagnostics effort with Signature’s expertise in both...
Inova offers a PGx test for newborns called MediMap™ as part of a standard package of services at Inova Women's Hospital located at Inova Fairfax Medical Campus.

Case Study: Translating from Molecules to Medicine

Clinicians need to understand the implications of genetic tests quickly and in clinical context.
Source: Getty Images

Study Identifies Barriers to Payer Coverage for Hereditary Cancer Panels

All payers agreed with two of the five identified factors: Panels do not fit within current coverage frameworks and lack necessary evidence.
Genomenon will donate licenses allowing clinical scientists working with Rare Genomics Institute to access the company’s Mastermind Genomic Search Engine. Mastermind is designed to link data on DNA mutations from patients with citations from scientific publications

Genomenon Donates Literature Engine Licenses to Rare Genomics Institute

Mastermind is designed to link data on DNA mutations with journal citations, and to date has indexed nearly 6 million scientific articles
Source: Thermo Fisher Scientific

Thermo Fisher Intros New Benchtop NGS Line, Expands Oncomine Assay Offerings

The Ion GeneStudio S5 series' multichip design offers flexibility, while Oncomine portfolio adds liquid biopsy and immuno-oncology assays
Electron micrograph of Burkholderia cenocepacia bacteria. [B. Kumar

Genomic Plasticity Seen in Cystic Fibrosis Chronic Lung Infection Pathogen

New research could provide valuable information for understanding the genomic and phenotypic underpinnings of bacterial evolution.
SQI Diagnostics will partner with University Health Network (UHN) to create and license rapid multiplexed protein assays and a point-of-care (POC) diagnostic device designed to help transplant surgeons assess the suitability of lungs and other organs for transplantation

SQI Diagnostics Partners with UHN on Diagnostic for Lung Transplantation

Research partnership also aims to expand applicability of a point-of-care testing device for transplants to other organs other than lungs
Scroll Up